do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Comparison of and dpp-4_inhibitors [TUSOM | Pharmwiki]
Description
Lehto, S
![do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Comparison of and dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b)
Were not about a quick-fix crash diet that doesnt educate you on how to lead a healthier lifestyle
![do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Comparison of and dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.mclaren.org/Uploads/Public/Images/MPHO/ClinicalCorner_20210615_GLP_1.jpg)
Lancet 400(10366):18691881 Jastreboff AM, Kaplan LM, Fras JP, Wu Q, Du Y, Gurbuz S et al (2023) Retatrutide phase 2 obesity trial investigators
![do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Comparison of and dpp-4_inhibitors [TUSOM | Pharmwiki]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9032/6696077/cc6dde43ce58/ijerph-16-02720-sch001.jpg)
Tirzepatide is the active ingredient in Zepbound, a GLP-1 receptor agonist
![do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Comparison of and dpp-4_inhibitors [TUSOM | Pharmwiki]](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41574-020-0399-8/MediaObjects/41574_2020_399_Fig1_HTML.png)
The difference is FDA approval: Mounjaro is approved for type 2 diabetes, and Zepbound is approved for chronic weight management
![do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Comparison of and dpp-4_inhibitors [TUSOM | Pharmwiki]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eee/12683481/5e5d3d32f437/PDS-34-e70277-g002.jpg)
Cell, 153(6), 11941217
![do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Comparison of and dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.mdpi.com/cells/cells-14-00387/article_deploy/html/images/cells-14-00387-g002-550.jpg)